Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders
1. ZimVie is under investigation for fiduciary duty breaches related to ARCHIMED transaction. 2. Shareholders are set to receive $19.00 per share, totaling $730 million. 3. Insiders may gain substantial benefits from change of control arrangements. 4. The deal potentially limits competing bids due to significant penalties. 5. Investigation questions the board's fulfillment of fiduciary duties to shareholders.